Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Opioid Reduction in Severe Trauma (KLOE)
NCT04833816Phase 3Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Aug 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in traumatic injury, sponsored by Assistance Publique-Hôpitaux de Marseille. Started Aug 2022; status: completed.
02
Drugs
ketamine
03
Conditions
traumatic injury
Beyond the preview
Go deeper on NCT04833816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833816.